The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells

Donata Vitagliano(Institute for Experimental Endocrinology and Oncology), Massimo Santoro(Institute for Experimental Endocrinology and Oncology)
Endocrine Related Cancer
October 13, 2010
10.1677/erc-09-0292
Cited by 73

Related Papers

Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
|Endocrine Related Cancer|2008|40
Supplementary Table 2 from A Cell Proliferation and Chromosomal Instability Signature in Anaplastic Thyroid Carcinoma
|Unknown|2023|0